Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial-Reference-Cited by-同舟云学术

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

Published:2012-06 Issue:6 Volume:11 Page:493-502
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Nobile-Orazio Eduardo,Cocito Dario,Jann Stefano,Uncini Antonino,Beghi Ettore,Messina Paolo,Antonini Giovanni,Fazio Raffaella,Gallia Francesca,Schenone Angelo,Francia Ada,Pareyson Davide,Santoro Lucio,Tamburin Stefano,Macchia Roberta,Cavaletti Guido,Giannini Fabio,Sabatelli Mario

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference37 articles.

1. Chronic inflammatory demyelinating polyradiculoneuropathy;Hahn,2005

2. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition;Vallat;Lancet Neurol,2010

3. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tattori Prefecture, Japan, Psychiatry;Kusumi;Clin Neurosci,1995

4. Incidence and prevalence of CIDP and the associations with diabetes mellitus;Laughlin;Neurology,2009

5. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England;Lunn;J Neurol Neurosurg Psychiatry,1999

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of steroid use in peripheral nerve pathologies and treatment;Frontiers in Neurology;2024-09-02

2. Treatment response amplitude and timing in chronic inflammatory demyelinating polyneuropathy with routine care: Study of a UK cohort;European Journal of Neurology;2024-07-09

3. Response to therapy in patients with chronic inflammatory demyelinating polyradiculoneuropathy: An observational study;Neurology Asia;2024-06

4. Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies;Journal of Neurology, Neurosurgery & Psychiatry;2024-05-10

5. Therapeutic progress and future prospects of chronic inflammatory demyelinating polyradiculoneuropathy;Clinical and Experimental Neuroimmunology;2024-04-23